Global Peripheral Vascular Devices Market is Estimated to Value Over USD 14.8 Billion by 2026 End

  • 20 Sep 2019

Global Peripheral Vascular Devices Market  is estimated to value over USD 14.8 billion by 2026 end and register a CAGR of over 5.8% during the forecast period 2019 to 2026.


The peripheral vascular devices market growth is steered by the increasing geriatric population, rising incidences of diabetes and the growing prevalence of peripheral artery diseases across the world. On the contrary, product failures and recalls and the availability of alternative treatments are the main factors that are anticipated to impede the market growth over the forecast period.


North America to Dominate the Market Over the Forecast Period

The market is bifurcated based on the type of device as peripheral transluminal angioplasty (PTA) balloon catheters, chronic total occlusion (CTO) devices, peripheral vascular stents, synthetic surgical grafts, peripheral transluminal angioplasty (PTA) guidewires, atherectomy devices, aortic stents, inferior vena cava filters and embolic protection devices. The atherectomy devices segment is anticipated to dominate the global market due to lifestyle-related disorders, rising obesity and the increasing prevalence of atherosclerosis. 


North America led the peripheral vascular devices market in 2018 and is predicted to grow in the future owing to factors like the strong presence of industry players, the rising number of cases related to cardiovascular diseases and growing geriatric population in the region. Europe is the second-largest market region followed by the Asia Pacific region.


Key market players in the peripheral vascular devices market are Medtronic (Ireland), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), B. Braun Melsungen (Germany), Biosensors International Group (Singapore), BIOTRONIK SE & Co. KG (Germany), Penumbra Inc.


Medtronic is the leading key player of peripheral vascular devices industry. It accounted for the largest peripheral vascular devices market share in 2017. The company mainly emphasizes on organic strategies to establish its position in the peripheral vascular devices market. It has been investing over 8% of its total revenue on research and development for instigating innovative products in the market.

Boston Scientific is another big major player of the peripheral vascular devices market. The company received FDA approval for Eluvia, a drug-emitting vascular stent system for PAD treatment in 2018. Furthermore, Boston Scientific and C.R Bard agreed to distribute the Lutonix 035 Drug-Coated Balloon Percutaneous Transluminal Angioplasty Catheter (Lutonix DCB) in the United States. 


Global Peripheral Vascular Devices Market Segmentation:

By Type

· Angioplasty Balloons

o Old/Normal Balloons

o Cutting and Scoring Balloons

o Drug-Eluting Balloons

· Angioplasty Stents

o Drug-Eluting Stents

o Bare-Metal Stents

§ Balloon-Expandable Stents

§ Self-Expandable Stents

· Catheters

o Angioplasty Catheters

o Guiding Catheters

o IVUXS/OCT Catheters

· Endovascular Aneurysm Repair Stent Graft

o Abdominal Aortic Aneurysm Stent Grafts

o Thoracic Aortic Aneurysm Stent Grafts

· Inferior Vena Cava Filters

o Retrievable Filters

o Permanent Filters

· Plaque Modification Devices

o Atherectomy Devices

o Thrombectomy Devices

· Hemodynamic Flow Alteration Devices

o Embolic Protection Devices

o Chronic Total Occlusion (CTO)


· Others

o Guidewires

o Vascular Closure Devices

o Introducer Sheaths

o Balloon Inflation Devices


By Region

· North America

· Europe

· Asia Pacific

· Rest of the World


FutureWise Key Takeaways:

• Growth prospects

• SWOT analysis 

• Key trends 

• Key data-points affecting market growth 


Objectives of the Study:

  • To provide with an exhaustive analysis on the global peripheral vascular devices market by type and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— Europe, North America, Asia Pacific and the rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Get unlimited analyst support and customise this study further to your requirements, contact